<?xml version="1.0" encoding="UTF-8"?>
<p>The unweighted prevalence was 29.8% (27.4-32.3) for HIV and 70.4% (67.9-72.8) for HCV. After weighting with the RDSATÂ® estimator, the prevalence remained very similar (Supplementary Table 
 <xref ref-type="supplementary-material" rid="supplementary-material-1">S2</xref>). Therefore, we conducted further analyses considering samples as a representative of the population of interest without accounting for the design effect.
</p>
